These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 20689253)

  • 1. Bladder preservation strategy based on combined therapy in patients with muscle-invasive bladder cancer: management and results at long-term follow-up.
    Villavicencio H; Rodriguez Faba O; Palou J; Gausa L; Algaba F; Marcuello E
    Urol Int; 2010; 85(3):281-6. PubMed ID: 20689253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bladder preservation in selected patients with muscle-invasive bladder cancer by complete transurethral resection of the bladder plus systemic chemotherapy: long-term follow-up of a phase 2 nonrandomized comparative trial with radical cystectomy.
    Solsona E; Climent MA; Iborra I; Collado A; Rubio J; Ricós JV; Casanova J; Calatrava A; Monrós JL
    Eur Urol; 2009 Apr; 55(4):911-9. PubMed ID: 18722046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is pure laparoscopic radical cystectomy still an attractive solution for the treatment of muscle-invasive bladder cancer?
    Chlosta P; Drewa T; Dobruch J; Antoniewicz A; Olejniczak P; Obarzanowski M; Borowka A
    Urol Int; 2010; 85(3):291-5. PubMed ID: 20389046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphovascular invasion and the presence of more than three tumors are associated with poor outcomes of muscle-invasive bladder cancer after bladder-conserving therapies.
    Zhang M; Tao R; Zhang C; Shen Z
    Urology; 2010 Oct; 76(4):902-7. PubMed ID: 20709377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncological outcome of primary versus secondary muscle-invasive bladder cancer is comparable after radical cystectomy.
    Aziz A; Gierth M; Fritsche HM; May M; Otto W; Denzinger S; Wieland WF; Merseburger A; Riedmiller H; Kocot A; Burger M
    Urol Int; 2013; 91(1):97-102. PubMed ID: 23751372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editorial comment on: Bladder preservation in selected patients with muscle-invasive bladder cancer by complete transurethral resection of the bladder plus systemic chemotherapy: long-term follow-up of a phase 2 nonrandomized comparative trial with radical cystectomy.
    Herr HW
    Eur Urol; 2009 Apr; 55(4):920-1. PubMed ID: 18722043
    [No Abstract]   [Full Text] [Related]  

  • 7. Editorial comment on: Bladder preservation in selected patients with muscle-invasive bladder cancer by complete transurethral resection of the bladder plus systemic chemotherapy: long-term follow-up of a phase 2 nonrandomized comparative trial with radical cystectomy.
    Witjes JA
    Eur Urol; 2009 Apr; 55(4):919. PubMed ID: 18722044
    [No Abstract]   [Full Text] [Related]  

  • 8. Surgical bladder preserving strategies in the treatment of muscle-invasive bladder cancer.
    Kuczyk M; Machtens S; Bokemeyer C; Kollmannsberger C; Hartmann J; Kondoh M; Merseburger A; Jonas U
    World J Urol; 2002 Aug; 20(3):183-9. PubMed ID: 12196902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of superficial bladder carcinoma: time to rethink the treatment strategies in the era of orthotopic neo-bladder.
    Singh PB; Kumar A; Das SK; Pandey AK; Sharma GK; Samir Swain HB; Trivedi S; Dwivedi US
    Saudi J Kidney Dis Transpl; 2010 Sep; 21(5):881-5. PubMed ID: 20814125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Four years experience in bladder preserving management for muscle invasive bladder cancer.
    Lodde M; Palermo S; Comploj E; Signorello D; Mian C; Lusuardi L; Longhi E; Zanon P; Mian M; Pycha A
    Eur Urol; 2005 Jun; 47(6):773-8; discussion 778-9. PubMed ID: 15925072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Radical cystectomy in patients with non-muscle invasive bladder cancer who fail BCG therapy].
    Huguet J; Gaya JM; Sabaté S; Palou J; Villavicencio H
    Actas Urol Esp; 2010 Jan; 34(1):63-70. PubMed ID: 20223134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organ preservation for muscle-invasive bladder cancer by transurethral resection.
    Leibovici D; Kassouf W; Pisters LL; Pettaway CA; Wu X; Dinney CP; Grossman HB
    Urology; 2007 Sep; 70(3):473-6. PubMed ID: 17905099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bladder-sparing multimodality treatment of muscle-invasive bladder cancer: a five-year follow-up.
    Given RW; Parsons JT; McCarley D; Wajsman Z
    Urology; 1995 Oct; 46(4):499-504; discussion 504-5. PubMed ID: 7571218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bladder function preservation with brachytherapy, external beam radiation therapy, and limited surgery in bladder cancer patients: Long-term results [corrected].
    Aluwini S; van Rooij PH; Kirkels WJ; Boormans JL; Kolkman-Deurloo IK; Wijnmaalen A
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):611-7. PubMed ID: 24411629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is robotic radical cystectomy an appropriate treatment for bladder cancer? Short-term oncologic and clinical follow-up in 50 consecutive patients.
    Pruthi RS; Wallen EM
    Urology; 2008 Sep; 72(3):617-20; discussion 620-2. PubMed ID: 18586308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal timing of radical cystectomy for patients with T1 bladder cancer.
    Bochner BH
    Urol Oncol; 2009; 27(3):329-31. PubMed ID: 19414124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of bladder-conserving strategies in muscle-invasive bladder carcinoma compared with radical surgery.
    Merseburger AS; Kuczyk MA
    Curr Opin Urol; 2007 Sep; 17(5):358-62. PubMed ID: 17762631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcome of high-grade non-muscle-invasive bladder cancer: a long-term single center experience.
    Iida S; Kondo T; Kobayashi H; Hashimoto Y; Goya N; Tanabe K
    Int J Urol; 2009 Mar; 16(3):287-92. PubMed ID: 19207115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
    Raman JD; Sosa RE; Vaughan ED; Scherr DS
    Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.